Dr. Reddy's Gets $72M In Generic Suboxone Settlement
Indivior, Aquestive and Dr. Reddy's Laboratories have ended their yearslong litigation battle over generic versions of the opioid addiction treatment Suboxone, with the Indian drugmaker on Friday saying it will receive...To view the full article, register now.
Already a subscriber? Click here to view full article